Detalhe da pesquisa
1.
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.
J Eur Acad Dermatol Venereol
; 37(9): 1815-1824, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014287
2.
Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.
Oncologist
; 24(4): e149-e153, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30902915
3.
Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.
Acta Derm Venereol
; 96(1): 23-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721372
4.
Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review.
J Dermatolog Treat
; 33(8): 3104-3118, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043844
5.
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
JAMA Dermatol
; 158(5): 561-572, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353175
6.
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment.
JAMA Dermatol
; 151(6): 616-22, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807311
7.
Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.
J Invest Dermatol
; 134(9): 2351-2360, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658504
8.
Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up.
JAMA Dermatol
; 150(2): 130-6, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24352354